Alerts will be sent to your verified email
Verify EmailCHANDAN
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Chandan Healthcare specializes in operating state-of-the-art laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provides an extensive array of radiology services, including CT scans, X-rays, and MRIs.
Chandan Healthcare major competitors are Kerala Ayurveda, Sudarshan Pharma Ind, Jenburkt Pharma.
Market Cap of Chandan Healthcare is ₹624 Crs.
While the median market cap of its peers are ₹629 Crs.
Chandan Healthcare seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | ||||||||||||||||||
Investor Presentation | ||||||||||||||||||
Conference Call | ||||||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|